Balyasny Asset Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.23M Buy
53,226
+25,504
+92% +$5.23M 0.01% 1072
2025
Q4
$7.1M Sell
27,722
-66,300
-71% -$17.4M 0.01% 1207
2025
Q3
$24.5M Sell
94,022
-178,003
-65% -$46.8M 0.03% 626
2025
Q2
$66.5M Buy
272,025
+208,086
+325% +$51.9M 0.1% 237
2025
Q1
$16.9M Buy
63,939
+39,601
+163% +$10.7M 0.03% 670
2024
Q4
$6.17M Sell
24,338
-91,867
-79% -$24.6M 0.01% 1179
2024
Q3
$36.8M Sell
116,205
-210,544
-64% -$74.9M 0.06% 411
2024
Q2
$122M Buy
326,749
+5,020
+2% +$1.69M 0.21% 90
2024
Q1
$112M Buy
321,729
+268,226
+501% +$102M 0.19% 96
2023
Q4
$24.5M Sell
53,503
-42,644
-44% -$21M 0.05% 523
2023
Q3
$46.8M Buy
96,147
+79,466
+476% +$37.3M 0.1% 288
2023
Q2
$7.46M Sell
16,681
-61,243
-79% -$30.8M 0.02% 908
2023
Q1
$37.8M Buy
+77,924
New +$38.5M 0.09% 301
2022
Q4
Sell
-5,474
Closed -$2.66M 2970
2022
Q3
$2.66M Sell
5,474
-65,539
-92% -$31.9M 0.01% 1345
2022
Q2
$33.2M Buy
71,013
+62,364
+721% +$27.7M 0.11% 263
2022
Q1
$3.76M Buy
8,649
+3,568
+70% +$1.49M 0.01% 1072
2021
Q4
$2.36M Sell
5,081
-30,745
-86% -$13.6M 0.01% 1153
2021
Q3
$13.9M Sell
35,826
-61,798
-63% -$26.2M 0.06% 450
2021
Q2
$43.2M Buy
97,624
+77,019
+374% +$33.6M 0.2% 110
2021
Q1
$8.64M Buy
20,605
+18,801
+1,042% +$7.51M 0.04% 528
2020
Q4
$740K Buy
+1,804
New +$750K ﹤0.01% 1071
2020
Q3
Sell
-30,899
Closed -$12M 1426
2020
Q2
$12M Buy
+30,899
New +$11.6M 0.1% 297
2020
Q1
Sell
-4,704
Closed -$1.72M 1302
2019
Q4
$1.72M Buy
+4,704
New +$1.49M 0.01% 782
2019
Q3
Sell
-93,367
Closed -$24.8M 1352
2019
Q2
$24.8M Buy
93,367
+80,959
+652% +$20.5M 0.16% 186
2019
Q1
$3.3M Buy
12,408
+11,692
+1,633% +$3.37M 0.02% 681
2018
Q4
$205K Sell
716
-14,710
-95% -$4.66M ﹤0.01% 1297
2018
Q3
$5.22M Buy
15,426
+13,436
+675% +$4.37M 0.02% 684
2018
Q2
$592K Sell
1,990
-26,509
-93% -$7.76M ﹤0.01% 1294
2018
Q1
$7.66M Sell
28,499
-50,425
-64% -$13.7M 0.03% 592
2017
Q4
$19.6M Sell
78,924
-68,917
-47% -$17M 0.06% 414
2017
Q3
$36M Buy
147,841
+97,204
+192% +$23.8M 0.14% 200
2017
Q2
$12.2M Sell
50,637
-5,119
-9% -$1.16M 0.05% 477
2017
Q1
$11.5M Sell
55,756
-16,642
-23% -$3.44M 0.05% 449
2016
Q4
$14.8M Sell
72,398
-85,102
-54% -$16.2M 0.08% 357
2016
Q3
$27.9M Sell
157,500
-84,502
-35% -$14.7M 0.16% 182
2016
Q2
$43.5M Buy
242,002
+239,942
+11,648% +$42.6M 0.28% 91
2016
Q1
$377K Buy
+2,060
New +$357K ﹤0.01% 952
2015
Q4
Sell
-6,620
Closed -$1.19M 1324
2015
Q3
$1.19M Sell
6,620
-14,128
-68% -$2.61M 0.01% 719
2015
Q2
$3.97M Buy
+20,748
New +$3.85M 0.02% 642
2015
Q1
Sell
-42,807
Closed -$6.15M 1003
2014
Q4
$6.15M Sell
42,807
-21,813
-34% -$2.98M 0.06% 391
2014
Q3
$8.42M Buy
64,620
+32,420
+101% +$4.12M 0.07% 345
2014
Q2
$4.11M Buy
+32,200
New +$3.81M 0.05% 417
2013
Q3
Sell
-48,834
Closed -$4.12M 626
2013
Q2
$4.12M Buy
+48,834
New +$3.85M 0.07% 337

Other funds holding HUM

Balyasny Asset Management's HUM Position: Q1 2026 in Review

Balyasny Asset Management increased its Humana (HUM) stake by 92% in Q1 2026, buying an estimated $5.23M and bringing the position to 53,226 shares worth $9.23M. The position accounts for 0.01% of the portfolio, ranked #1072.

Balyasny Asset Management first reported a position in HUM in Q2 2013 and has held it in 43 quarters since. The position peaked at $122M in Q2 2024. 780 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Balyasny Asset Management held 53,226 shares of Humana worth $9.23M as of Q1 2026.
  • Balyasny Asset Management bought 25,504 Humana shares in Q1 2026, an estimated $5.23M.
  • Humana made up 0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1072 holding.
  • Balyasny Asset Management first reported a position in Humana in Q2 2013 and has held it in 43 quarters since.
  • Balyasny Asset Management's Humana position peaked at $122M in Q2 2024.
  • 780 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.